| Pili, Roberto |
| Recruiting | 3 | 738 | Europe, US, RoW | Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223 | Memorial Sloan Kettering Cancer Center, Bayer | Prostate Cancer | 06/26 | 06/26 | | |
NCT03552380: Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma |
|
|
| Terminated | 2 | 12 | US | Entinostat, MS-275, SND-275, Nivolumab, Opdivo, Ipilimumab, Yervoy | Roberto Pili, Bristol-Myers Squibb, Syndax Pharmaceuticals, Indiana University School of Medicine | Renal Cell Carcinoma | 06/22 | 02/24 | | |
| Active, not recruiting | 2 | 46 | US | Entinostat, Interleukin-2, aldesleukin | Roberto Pili, Indiana University Melvin and Bren Simon Cancer Center, Syndax Pharmaceuticals, Clinigen, Inc. | Renal Cell Carcinoma | 01/23 | 04/24 | | |
BRCAAway, NCT03012321: Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects |
|
|
| Active, not recruiting | 2 | 70 | US | Olaparib, Lynparza, Abiraterone Acetate, Prednisone | Northwestern University, AstraZeneca, National Cancer Institute (NCI) | Prostate Cancer Metastatic Castration-Resistant, Abnormal DNA Repair, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer | 12/26 | 01/27 | | |
NCT06222593: Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination with Sunitinib in Patients with TKIs-resistant RCC |
|
|
| Not yet recruiting | 1/2 | 28 | NA | Bicalutamide in combination with Sunitinib, (RS)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl sulfonyl]-2-hydroxy-2-methylpropanamide, UNII: A0Z3NAU9DP, CASODEX | State University of New York at Buffalo | Carcinoma, Renal Cell | 07/25 | 07/26 | | |
ADAPT-BLADDER, NCT03317158: Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder |
|
|
| Recruiting | 1/2 | 55 | US | Durvalumab (Cohort 1-3), Imfinzi, External Beam Radiotherapy (EBRT), Bacillus Calmette-Guérin (BCG), Gemcitabine, Gemzar, Docetaxel, Taxotere, Tremelimumab, Durvalumab (Cohort 4/5), To be determined | Noah Hahn, M.D., AstraZeneca, Hoosier Cancer Research Network | Urothelial Carcinoma, Bladder Cancer | 12/25 | 12/26 | | |
NCT02619253: Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma |
|
|
| Completed | 1 | 52 | US | Pembrolizumab, Keytruda, Vorinostat, Zolinza | Nabil Adra | Renal Cell Carcinoma, Urinary Bladder Neoplasms | 03/23 | 03/23 | | |
NCT05359848: A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy |
|
|
| Recruiting | N/A | 30 | US | Diet | State University of New York at Buffalo | Medical Oncology, Integrative Oncology, Medical Nutrition Therapy | 12/24 | 06/25 | | |
NCT06172283: Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy |
|
|
| Recruiting | N/A | 30 | US | Intermittent Fasting | State University of New York at Buffalo | Prostate Cancer | 01/27 | 12/28 | | |
NCT05356182: A Pilot and Feasibility Study of a Dietary Intervention with Low-protein Meals in Cancer Patients Receiving Immunotherapies |
|
|
| Recruiting | N/A | 30 | US | Diet | State University of New York at Buffalo | Medical Oncology, Integrative Oncology, Medical Nutrition Therapy | 04/25 | 04/25 | | |
| Guttuso, Thomas |
NCT05618587: Effect of Lithium Therapy on Long COVID Symptoms |
|
|
| Completed | 2 | 50 | US | Lithium, Placebo | State University of New York at Buffalo, National Center for Advancing Translational Sciences (NCATS) | Long COVID | 07/23 | 07/23 | | |
NCT06339034: Repurposing Lithium for Parkinson's Disease: a RCT |
|
|
| Recruiting | 1/2 | 20 | US | Lithium, Placebo | State University of New York at Buffalo, The Cure Parkinson's Trust | Parkinson Disease | 08/25 | 10/25 | | |
| Enrolling by invitation | 1/2 | 35 | US | Lithium aspartate | State University of New York at Buffalo | Parkinson Disease | 02/26 | 05/26 | | |
| Sheperd, Rachel |
| No trials found |
| Coleman, Deonna |
| No trials found |
